Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring

Diabetes Technology and Therapeutics

Volumn 14, Issue 8, 2012, Pages 736-740

  Ritz, Patrick ^a,b   Vaurs, Charlotte ^a   Bertrand, Monelle ^a   Anduze, Yves ^c   Guillaume, Eric ^d   Hanaire, Helene ^d,e  

^a SERVICE DE PNEUMOLOGIE   (France)

^b Faculté de Médecine Centre Hospitalo universitaire   (France)

^c Cèdres Clinic   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e University Hospital of Toulouse   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLUCOSE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GLYCEMIC CONTROL; GLYCEMIC INDEX; HUMAN; MALE; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; PILOT STUDY; POSTGASTRECTOMY SYNDROME; PRIORITY JOURNAL; ROUX EN Y GASTRIC BYPASS; STOMACH BYPASS; SYMPTOM; THERAPY EFFECT; TREATMENT DURATION;

ACARBOSE; ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIRECTIVE COUNSELING; DUMPING SYNDROME; FEMALE; FOOD HABITS; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 84864705219     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0302     Document Type: Article

References (21)

1. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I: Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-256.e5.
2. Bantle JP, Ikramuddin S, Kellogg TA, Buchwald H: Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg 2007;17:592-594.
3. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ, Patti ME: Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007;92:4678-4685.
4. Kellogg TA, Bantle JP, Leslie DB, Redmond JB, Slusarek B, Swan T, Buchwald H, Ikramuddin S: Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis 2008;4:492-499.
5. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV: Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005;353:249-254.
6. Ritz P, Hanaire H: Post-bypass hypoglycaemia: a review of current findings. Diabetes Metab 2011;37:274-281.
7. Tack J, Arts J, Caenepeel P, De Wulf D, Bisschops R: Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 2009; 6:583-590.
8. Halperin F, Patti ME, Skow M, Bajwa M, Goldfine AB: Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes 2011;2011:869536.
9. Peterli R, Wölnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, von Flüe M, Beglinger C: Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009;250:234-241.
10. Rodieux F, Giusti V, D'Alessio DA, Suter M, Tappy L: Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 2008; 16:298-305.
11. Vidal J, Nicolau J, Romero F, Casamitjana R, Momblan D, Conget I, Morínigo R, LacyAM: Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab 2009;94:884-891.
12. Hanaire H, Bertrand M, Guerci B, Anduze Y, Guillaume E, Ritz P: High glycemic variability assessed by continuous glucose monitoring after surgical treatment of obesity by gastric bypass. Diabetes Technol Ther 2011;13:625-630.
13. Hanaire H, Dubet A, Chauveau ME, Anduze Y, Fernandes M, Melki V, Ritz P: Usefulness of continuous glucose monitoring for the diagnosis of hypoglycemia after a gastric bypass in a patient previously treated for type 2 diabetes. Obes Surg 2010;20:126-129.
14. Hasegawa T, Yoneda M, Nakamura K, Ohnishi K, Harada H, Kyouda T, Yoshida Y, Makino I: Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome. J Gastroenterol Hepatol 1998;13:1201-1206.
15. Lyons TJ, McLoughlin JC, Shaw C, Buchanan KD: Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome. Digestion 1985;31:89-96.
16. McLoughlin JC, Buchanan KD, Alam MJ: A glycosidehydrolase inhibitor in treatment of dumping syndrome. Lancet 1979;2:603-605.
17. Moreira RO, Moreira RB, Machado NA, Goncalves TB, Coutinho WF: Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 2008;18:1618-1621.
18. Topart P, Becouarn G, Ritz P: Biliopancreatic diversion with duodenal switch or gastric bypass for failed gastric banding: retrospective study from two institutions with preliminary results. Surg Obes Relat Dis 2007;3:521-525.
19. Fox LA, Beck RW, Xing D: Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care 2010;33: 1297-1299.
20. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
21. Ozgen AG, Hamulu F, Bayraktar F, Cetínkalp S, Yilmaz C, Túzún M, Kabalak T: Long-term treatment with acarbose for the treatment of reactive hypoglycemia. Eat Weight Disord 1998;3:136-140.